Mepro is committed to serve humanity by helping eradicate diseases and helping the less fortunate by providing healthcare to everyone. With the current ongoing global pandemic, COVID-19, Mepro has globally collaborated and has provided for emergency stock-pile support therapies for coronavirus treatments for deeply affected countries in Latin America. Mepro stands for and is determined to provide access to its efficacious products for meaningful and progressive endeavours for an overall societal well-being.

As the name suggests, ‘Neglected’ Tropical Diseases like Soil Transmitted Helminths (STH) or simply put ‘Intestinal worms’ are indeed vastly neglected in Low & Middle Income countries of Africa and Asia. This is particularly disconcerting when an estimated 266 million preschool children are at the risk of STH infections, which, if left untreated can cause abdominal pain/distention, stunted growth, anemia, impaired cognitive development, and compromised nutrition. In a bid to eradicate this, Mepro has tied up with a global non-profit organisation for manufacturing and supply of a drug in its treatment therapy. Through its partners vast distribution network, approximately 42 million children in the age bracket of 12-59 months are being reached out to and treated each year.

Mepro has been a partner of choice to quite a few United Nations organizations since more than a decade. It’s through one of these organizations, Mepro is supporting healthcare needs of almost 5.6 million Palestinian refugees now residing across West bank, Gaza, Lebanon, Jordan and Syria. This has been stitched across 10 products in acute as well as chronic segments under a long-term supply and sustenance agreement.